genetic factors is supported by studies in twins.
INTRODUCTION
Of individuals addicted to alcohol, approximately 10-20% will develop cirrhosis, 5% will develop acute or chronic pancreatitis and 1% will develop both disorders.
include genes that are translated into enzymes which metabolize both ethanol to acetaldehyde (alcohol dehydrogenase [ADH] , cytochrome P450-2E1 [CYP2E1]) and acetaldehyde to acetate (aldehyde dehydrogenase [ALDH] ). For ADH, there are at least six genes, ADH1-6. 4 Two of these (ADH2 and ADH3) are polymorphic, with three alleles (ADH2*1, ADH2*2 and ADH2*3) and two alleles (ADH3*1 and ADH3*2), respectively.These genotypes are translated into peptide subunits b1-3 for ADH2 and g1-2 for ADH3. Genotypes associated with enzymes of low activity are ADH2*1/*1 and ADH3*2/*2. The enzyme CYP2E1 contributes to ethanol metabolism at high concentrations of alcohol, is inducible by alcohol, and has genetic polymorphisms in the 5¢-flanking region (alleles c1 and c2) and in intron 6 (alleles D and C). The presence of the c2 allele is associated with enhanced enzyme activity. 5, 6 For ALDH, there are two genes, ALDH1 and ALDH2. ALDH2 is largely responsible for enzyme activity and is polymorphic, with two alleles (ALDH2*1 and *2). Homozygotes for ALDH2*2 are deficient in ALDH2 activity and rarely consume alcohol because of side-effects from higher concentrations of acetaldehyde. 7 This genotype is common in some Asian populations (Japanese and Chinese) but appears to be rare in Caucasian populations. 7, 8 Genotypes of possible relevance to alcohol toxicity include glutathione S-transferases (GST) and apolipoprotein E. The former are a large family of enzymes which catalyze the conjugation of acetaldehyde to glutathione and facilitate the elimination of free radicals. At least two members of the family (GSTM1 and GSTT1) show deletion mutations which are relatively common in Caucasian populations. 9 Apolipoprotein E genotypes might also influence susceptibility to pancreatitis or cirrhosis, as apolipoprotein-e4 is associated with some elevation of blood lipids. 10 This study compared the frequencies of the above genotypes in patients with alcoholic cirrhosis and alcoholic chronic pancreatitis to those in alcoholic controls (apparently without organ damage) and control subjects recruited from a blood bank. Components of this study have been addressed in a number of publications from other countries, particularly in patients with alcoholic cirrhosis. 11 For example, in a multicenter study in Europe, alcoholics and patients with alcoholic cirrhosis had a similar frequency of ADH2 and ADH3 alleles to
178
A Frenzer et al.
those in control subjects. However, when subjects were grouped as alcoholic compared to non-alcoholic, the former had a marginally higher frequency of ADH2*1 (98.7%) than the latter (96.2%). 12 In another large study from the United Kingdom, there was a nonsignificant excess of the rare c2 allele of CYP2E1 in subjects with alcoholic liver disease, while male subjects with liver disease had a higher than expected frequency of ADH3*2/*2. 13 In Asia, inheritance of the ALDH2*2 allele is associated with a low risk for alcoholism, and this may also apply to ADH2*2 and ADH3*1. 8, 14 However, when heterozygotes with ALDH2*2 abuse alcohol, they appear to be at higher risk for the development of cirrhosis. 15 In Japan, some studies have shown an association between the c2 allele of CYP2E1 and alcoholic liver disease. [16] [17] [18] Thus far, apart from an association with ADH2*2/*2 in Japan, 19 inherited variation in alcohol metabolism has not been implicated in susceptibility to chronic pancreatitis.
PATIENTS AND METHODS

Patients
The case-control study was performed in two major teaching hospitals in Australia, the Queen Elizabeth Hospital, Adelaide and the Prince of Wales Hospital, Sydney. All subjects were Caucasian adults: 57 with alcoholic cirrhosis, 71 with alcoholic chronic pancreatitis, 57 alcoholic controls without apparent organ damage and 200 blood donors. Mean age, gender ratios and estimated consumption of alcohol over the previous 5 years are shown in Table 1 .
Patients with cirrhosis were diagnosed either by liver biopsy or had unequivocal clinical, radiological and endoscopic features of cirrhosis, including splenomegaly, ascites and esophageal varices. Various blood tests and/or liver biopsy excluded other causes for chronic liver disease such as hepatitis B and C, hemochromatosis, Wilson's disease, a-1-antitrypsin deficiency and autoimmune liver disorders.
Patients with alcoholic chronic pancreatitis had relapsing pancreatitis and additional evidence of chronic pancreatitis on retrograde pancreatography (ERCP) or computed tomography (CT) scan. There were 45 patients (63%) with calcification on a plain abdominal X-ray. Other causes for pancreatitis such as choledocholithiasis, hypercalcemia, hyperlipidemia and various drugs were excluded by history, blood tests and radiological investigations including ERCP.
Alcoholic controls were recruited from a detoxification center for alcoholics. None of these patients had clinical features of chronic liver disease such as splenomegaly, ascites and spider nevi. Furthermore, none had a previous history of pancreatitis. All patients had platelet counts and levels of plasma albumin, plasma transaminases and INR within the reference range. Healthy blood donors were recruited from a blood bank in Adelaide. The study was approved by Hospital Ethics Committees.
Methods
DNA was extracted from peripheral blood lymphocytes by proteinase-K digestion and phenol-chloroform extraction. 20 The genotypes were ascertained by PCR-RFLP using primers as shown in Table 2 . After PCR amplification, the products were digested with a variety of restriction enzymes for RFLP and analyzed by polyacrylamide or agarose gel electrophoresis and stained with ethidium bromide. For ADH2 genotyping, the restriction enzymes MaeIII and AlwN1 were used to determine the ADH2*1, ADH2*2 and ADH2*3 alleles. 21, 22 SspI was used in the ADH3 RFLP to determine the ADH3*1 and ADH3*2 alleles. 22 For ALDH2 genotyping, the restriction enzyme MboII was used to determine the ALDH2*1 and ALDH2*2 alleles. 23 To genotype CYP2E1, the restriction enzymes RsaI and PstI were used to determine the c1 and c2 alleles of the 5¢-flanking region, 24 while the enzyme DraI was used for
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the D and C alleles in intron 6. 25 GSTM1 and GSTT1 were genotyped by a multiplex PCR with an internal CD3g control. 26, 27 The amplified PCR band was either present or homozygously deleted (null-type).The e2, e3 and e4 alleles of apolipoprotein E were genotyped by PCR-RFLP with the restriction enzyme HhaI. 28 Cross-tabulations were analyzed using Fisher's exact test. Odds ratios (OR) and 95% confidence intervals (95% CI) were calculated using exact (permutational) methods. The possibility of linkage disequilibrium between various genotypes was examined using methods described by Mander. 29 With 200 controls and a frequency of ADH3*2/*2 of approximately 10%, the study had a power of 75% to detect an odds ratio of three.
Lower power values were obtained for genotypes such as GSTT1 and variants of CYP2E1.
RESULTS
The genotype and allelic frequencies for ADH2 and ADH3 are shown in Tables 3 and 4 . The genotype ADH3*2/*2 was more frequent in patients with cirrhosis than blood donors (OR 4.92; 95% CI 2.36-10.31) and patients with chronic pancreatitis (OR 7.33; 95% CI 2.54-23.78). However, differences between patients with cirrhosis and alcoholic controls were not statistically different (OR 2.27; 95% CI 0.95-5.66). A similar result was found for ADH2, where ADH2*1/*1 was more frequent in patients with cirrhosis than in blood donors and patients with chronic pancreatitis, but not more frequent than in alcoholic controls. For ADH2 frequencies, calculations of odds ratios were not possible as all cirrhotic patients had the genotype ADH2*1/*1. When the total alcoholic group (patients and controls) was compared to blood donors, there was a higher frequency of ADH3*2/*2 (OR 2.15; 95% CI 1.2-3.90) and a trend towards a higher frequency of ADH2*1/*1 (OR 1.79; 95% CI 0.69-5.01). The attributable risk of ADH3*2/*2 for alcoholic cirrhosis when compared to blood donors was 32%. Genotype frequencies for CYP2E1, GSTM1, GSTT1 and apolipoprotein E are shown in Tables 5 and 6 . Differences between groups were not statistically significant. For ALDH2, all subjects in the study had the genotype ALDH2*1/*1. The possibility of linkage disequilibrium between ADH2 and ADH3 was examined in the combined group of 385 subjects. As in a previous study, 12 there was evidence of linkage disequilibrium between ADH2 and ADH3 (P < 0.01), with associations between the alleles ADH2*1 and ADH3*2 and between ADH2*2 and ADH3*1. There was no evidence of linkage of
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ADH2 or ADH3 alleles to the rare c2 allele of CYP2E1. In alcoholic controls, there was no evidence that subjects with the ADH3*2/*2 genotype had a higher alcohol consumption than subjects with ADH3*1/*1 or ADH3*1/*2.
DISCUSSION
In this study, genotype frequencies in control groups were similar to those in other Caucasian populations.
In particular, at least 90% of subjects were homozygous for ADH2*1 while all subjects were homozygous for ALDH2*1. Furthermore, the c2 allele of CYP2E1 was present in heterozygous form in fewer than 10% of subjects. In relation to subject groups, there was the expected male predominance in alcoholic controls and in patients with cirrhosis and chronic pancreatitis. However, the mean age of alcoholic controls (42 years) was somewhat lower than other groups.
In patients with alcohol-induced organ damage, the only significant associations were between cirrhosis and genotypes of ADH. When compared to blood donors, patients with cirrhosis had a higher than expected frequency of ADH3*2/*2 and a marginally higher frequency of ADH2*1/*1. The latter seems likely to reflect linkage disequilibrium between ADH2 and ADH3. For both ADH3*2/*2 and ADH2*1/*1, the frequency in alcoholic controls was intermediate between that observed in patients with cirrhosis and blood donors. As both genotypes encode less active forms of ADH, one possibility is that these genotypes delay the formation of acetaldehyde, decrease side-effects from alcohol and permit higher intakes of alcohol in addicted individuals. Another possibility is that less active forms of ADH increase alcohol metabolism through non-ADH pathways such as CYP2E1 and the non-oxidative pathways. These pathways may be linked to accelerated organ damage through enhanced formation of free radicals and fatty acid ethyl esters, respectively. [30] [31] [32] Reasons for the more prominent association of ABH3*2/*2 with alcoholic cirrhosis in this study when compared to other studies in Caucasian populations 12, 13, 33 remain unclear. This may be due to chance or may reflect variation in the influence of alcohol consumption or other environmental factors in different countries. For example, when environmental influences on susceptibility to cirrhosis increase in importance, genetic influences will become more difficult to demonstrate. The finding that alcoholic controls had an intermediate frequency of ADH3*2/*2, between blood donors and patients with cirrhosis, may also be due to chance or may reflect inappropriate categorization of subjects (some alcoholics may develop cirrhosis). However, another possibility is that ADH3*2/*2 not only increases susceptibility to alcoholism but also increases the susceptibility of alcoholics to cirrhosis.
In contrast to cirrhosis, patients with chronic pancreatitis had a similar frequency of alcoholmetabolizing genotypes to alcoholic controls and blood donors. Furthermore, previous studies have not shown associations with genetic influences on blood lipids 34 or with genotypes for cystic fibrosis 35, 36 and hereditary chronic pancreatitis. 37 However, a recent study suggested an association between alcoholic chronic pan-
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creatitis and heterozygosity for a mutation in the pancreatic secretory serine protease inhibitor Kazal type 1 (SPINK1) gene. 38 Differences in genotype frequencies between alcoholics with cirrhosis and those with chronic pancreatitis raise the possibility of different mechanisms of alcohol-induced damage in the two diseases. One possibility is that the amount of alcohol consumed is more important in the development of cirrhosis than chronic pancreatitis, particularly as chronic pancreatitis often develops at a younger age. In cirrhosis, alcoholmetabolizing genotypes have some effect but this may differ in Caucasian and Oriental populations. In this study, cirrhosis was associated with ADH genotypes encoding less active alcohol-metabolizing enzymes that might either delay the formation of acetaldehyde (and permit higher intakes of alcohol) or divert alcohol metabolism through non-ADH pathways such as the CYP2E1 and the non-oxidative pathways.
Addendum
After submission of this article, Degoul et al. (Gastroenterology 2001; 120: 1468-74) reported an association between alcoholic cirrhosis and the Ala/Ala genotype in the mitochondrial targeting sequence of superoxide dismutase. We genotyped our patients and found that the frequency of Ala/Ala homozygotes was similar in patients with cirrhosis (17.6%) and chronic pancreatitis (22.0%) to those in the blood bank (26.7%) and alcoholic controls (11.5%). 
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